Opportunity ID: 353719
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HT942524TBDRPTDRA |
| Funding Opportunity Title: | DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 23, 2024 |
| Last Updated Date: | Apr 23, 2024 |
| Original Closing Date for Applications: | Oct 03, 2024 |
| Current Closing Date for Applications: | Oct 03, 2024 |
| Archive Date: | Nov 02, 2024 |
| Estimated Total Program Funding: | $2,656,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
The FY24 TBDRP Therapeutic/Diagnostic Research Award is intended to support therapeutic and diagnostic development research with demonstrated feasibility. Projects addressing an FY24 Treatment TBDRP Therapeutic/Diagnostic Research Award Focus Area should be therapeutic evaluation studies designed to advance drugs or treatments that are still in the preclinical stages of development. Projects addressing an FY24 Diagnosis TBDRP Therapeutic/Diagnostic Research Award Focus Area should be diagnostic evaluation studies to advance approaches that will be readily integrated into clinical settings. All research projects must have translational potential and aim to improve patient care and/or quality of life for military Service Members, Veterans, and their Families, as well as the American public living with Lyme disease and/or other tick-borne diseases and conditions. The proposed studies are expected to be experimental in nature and product-driven. Applicants with limited tick-borne disease experience are strongly encouraged to collaborate with experienced tick-borne disease investigators. Applicants with substantial tick-borne disease experience are strongly encouraged to partner with experts in therapeutic and diagnostic assay development and transition, particularly those from the commercial sector. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00286011 | Apr 23, 2024 | Oct 03, 2024 | View |
Package 1
Mandatory forms
Optional forms
Share This Post, Choose Your Platform!
About the Author: osnqt
